EU Commission's SCENIHR casts fresh eye over PIP implant safety, MoM hips
This article was originally published in Clinica
SCENIHR, the European Commission’s scientific committee that assesses emerging and newly identified health risks, is to give a second opinion in June on the safety of the controversial PIP silicone gel breast implants. The devices, which were filled with industrial-grade silicone and sold worldwide, became the centre of a public health storm at end of 2011 and threw the medtech industry - and the revision on the medical device directives - into turbulent waters last year.
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests are not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.